France
France-HiT
France-HiT
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Health systems in transition <strong>France</strong> 177<br />
drugs, has not otherwise appeared to be a priority. However, following the 2012<br />
National Strategy for Health goals, a new interministerial committee (Comité<br />
interministériel de la santé), comprising all ministers as well as the secretary<br />
of state for the budget, was created in June 2014 to ensure improvement in<br />
population health and reduction of health inequalities through improved<br />
coordination on all matters affecting health determinants (socioeconomic,<br />
geographic, environmental, educational, etc.; see section 6.2).<br />
7.2 Financial protection and equity in financing<br />
7.2.1 Financial protection<br />
Overall, financial protection of the French population is good. <strong>France</strong> is among<br />
the OECD countries for which public financing of health care expenditure is the<br />
highest and OOP spending is the lowest. In 2011, the Netherlands, the Czech<br />
Republic, Japan, Denmark, Norway and Sweden were the only countries with<br />
a higher share of publicly funded health expenditure. This is achieved through<br />
a strong commitment by the French to their public SHI (93% of the French<br />
population declare that the SHI system should remain publicly funded) and<br />
the 1999 Universal Health Coverage Act, which provided universal health care<br />
coverage for all people living in <strong>France</strong> (see section 3.2). In 2013, 77.4% of<br />
personal health expenditure was publicly funded, with the remainder financed<br />
by a combination of VHI (13.8%) and OOP payments (8.8%). Reduction of<br />
financial barriers for groups at greatest financial risk was partly achieved<br />
through the 1999 Universal Health Coverage Act by the provision of CMU-C<br />
and through the implementation of the ACS, which provides means-tested<br />
vouchers for VHI, thus reducing exposure to OOP expenditure (see section 3.3).<br />
However, the proportion of the population covered by complementary health<br />
insurance does not fully reflect the degree to which financial risk is covered.<br />
Indeed, there are large discrepancies within the covered population in terms<br />
of the cost of contracts and level of coverage (see section 7.2.2). While 94%<br />
of the population had complementary health insurance in 2012 (either VHI or<br />
CMU-C), among those covered by VHI, 70% say that hospitalization is well<br />
covered by their contracts, as opposed to vision correction (52%), extra-billing<br />
by specialists (48.5%) and dental prosthetics (46.4%) (Célant, Guillaume &<br />
Rochereau, 2014).